Feature Channels: Alzheimer's and Dementia

Filters close
Newswise: 1920_cedars-sinai-accelerator-nirdesh-gupta-jim-laur.jpg?10000
Released: 1-Aug-2024 10:05 AM EDT
Cedars-Sinai Accelerator Welcomes 10th Class of Health-Tech Startups
Cedars-Sinai

The Cedars-Sinai Accelerator program will greet its 10th accelerator class, featuring 10 innovative health-tech startup companies from the United States and around the globe.

Released: 31-Jul-2024 4:05 PM EDT
AAIC 2024
Newswise

The Alzheimer's Association International Conference (AAIC) 2024 is set to take place from July 28th to August 1st at the Pennsylvania Convention Center in Philadelphia, PA. As the premier event for Alzheimer's and dementia research, AAIC brings together scientists, clinicians, and care professionals from around the world to discuss the latest discoveries and innovations in the field.

Newswise: 1920_us-news-cedars-sinai.jpg?10000
Released: 31-Jul-2024 11:05 AM EDT
July Research Highlights Newsletter
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for July 2024.

24-Jul-2024 12:00 PM EDT
New test can detect patients’ risk of harmful side effects from Alzheimer's drugs
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Today at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will present data on a novel test that predicts whether Alzheimer’s patients are genetically predisposed to side effects from anti-amyloid drugs, a promising new class of Alzheimer’s therapeutics.

Newswise: Mejora de la imagenología de la enfermedad de Alzheimer con sensores fluorescentes
Released: 31-Jul-2024 9:05 AM EDT
Mejora de la imagenología de la enfermedad de Alzheimer con sensores fluorescentes
American Chemical Society (ACS)

Ahora investigadores deACS Central Science demuestran una forma de empaquetar sensores fluorescentes para facilitar su paso a través de la barrera hematoencefálica en ratones, lo que permite mejorar la obtención de imagenología cerebral. Con un mayor desarrollo, la tecnología podría contribuir a avanzar en el diagnóstico y el tratamiento de la enfermedad de Alzheimer.

   
Newswise: Improving Alzheimer’s disease imaging — with fluorescent sensors
26-Jul-2024 8:00 AM EDT
Improving Alzheimer’s disease imaging — with fluorescent sensors
American Chemical Society (ACS)

Now, researchers in ACS Central Science demonstrate a way of packaging fluorescent sensors for easy passage across the blood-brain barrier in mice, allowing for improved brain imaging. With further development, the technology could help advance Alzheimer’s disease diagnosis and treatment.

   
Released: 31-Jul-2024 6:05 AM EDT
Cortechs.ai Receives a New NIH Grant for ARIA Detection in Alzheimer's Disease
Cortechs.ai

Cortechs.ai is proud to announce that it has received a 3-year, multimillion dollar NIH grant. Cortechs.ai will use the grant to support the development of additional analysis software to automatically detect and quantify the Amyloid Related Imaging Abnormalities (ARIA) throughout the treatment of Alzheimer's patients to monitor the effects of the therapeutic intervention and to improve patient management.

29-Jul-2024 1:05 PM EDT
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
Washington University in St. Louis

A head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by researchers at Washington University School of Medicine in St. Louis reveals that two are accurate enough to replace brain scans and spinal taps in some patients with cognitive impairments.

Released: 30-Jul-2024 10:30 AM EDT
Expert on Alzheimer’s Therapeutic Development AAIC 2024
University of Miami Health System, Miller School of Medicine

Our grant proprosal is to identify how two protective mechanisms work and then test them in both European and Amerindian APOE4 genes to see if they work in those genetic backgrounds as well as African.

Newswise: Researchers Link Midlife Blood Biomarkers to Late-life Dementia Risk
Released: 30-Jul-2024 9:05 AM EDT
Researchers Link Midlife Blood Biomarkers to Late-life Dementia Risk
University of North Carolina School of Medicine

A research team led by Priya Palta, PhD, MHS, an associate professor of neurology at the UNC School of Medicine, has found that certain Alzheimer’s disease and neurodegenerative blood biomarkers in midlife and late life had strong associations with late-life dementia.

Released: 29-Jul-2024 5:05 PM EDT
Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo
ADLM 2024 Press Program

● Roche will unveil the next generation of core lab and molecular systems, including a total solution for clinical mass spectrometry. ● Attendees can experience firsthand how fully integrated systems and data solutions can streamline lab operations, optimize resources and expedite care.

Not for public release

This news release is embargoed until 25-Jul-2024 9:05 AM EDT Released to reporters: 24-Jul-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2024 9:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

19-Jul-2024 12:05 PM EDT
Does Your Body Composition Affect Your Risk of Dementia or Parkinson’s?
American Academy of Neurology (AAN)

People with high levels of body fat stored in their belly or arms may be more likely to develop diseases like Alzheimer’s and Parkinson’s than people with low levels of fat in these areas, according to a study published in the July 24, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 24-Jul-2024 6:00 AM EDT
Científicos de Mayo Clinic definen un nuevo tipo de pérdida de memoria en las personas mayores
Mayo Clinic

Investigadores de Mayo Clinic han establecido nuevos criterios para un síndrome de pérdida de memoria en las personas mayores que afecta específicamente al sistema límbico del cerebro. A menudo, este síndrome se puede confundir con la enfermedad de Alzheimer.

Newswise: UCLA selected by Centers for Medicare & Medicaid Services to test Medicare dementia care model
Released: 19-Jul-2024 5:05 PM EDT
UCLA selected by Centers for Medicare & Medicaid Services to test Medicare dementia care model
University of California, Los Angeles (UCLA), Health Sciences

UCLA has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.

Newswise: 1920_gettyimages-1486145188.jpg?10000
Released: 19-Jul-2024 1:05 PM EDT
Cedars-Sinai Programs Earn Distinction for Prioritizing Older Adults’ Needs
Cedars-Sinai

Cedars-Sinai programs serving older patients and people with dementia have earned esteemed national distinctions reserved for healthcare models that prioritize improved health and wellness among older adults—a rapidly growing segment of the U.S. population expected to nearly double in the coming decades.

Released: 19-Jul-2024 10:05 AM EDT
Wash U researchers shine light on amyloid architecture
Washington University in St. Louis

Researchers at Washington University in St. Louis use microscopy to chart amyloid beta’s underlying structure and yield insight into neurodegenerative disease

Newswise:Video Embedded curious-by-nature-why-is-metabolomics-important-to-alzheimer-s-dr-stewart-graham
VIDEO
Released: 19-Jul-2024 8:05 AM EDT
Curious by Nature: Why is Metabolomics Important to Alzheimer’s? - Dr. Stewart Graham
Newswise

In this episode, Dr. Stewart Graham discusses metabolomics in Alzheimer’s disease. He investigates how the disease affects the brain’s metabolism of small molecules such as lipids and amino acids.



close
2.81122